Moderate maternal drinking and outcome of pregnancy
✍ Scribed by F. Lazzaroni; S. Bonassi; M. Magnani; A. Calvi; E. Repetto; G. Serra; F. Podestà; N. Pearce
- Publisher
- Springer
- Year
- 1993
- Tongue
- English
- Weight
- 650 KB
- Volume
- 9
- Category
- Article
- ISSN
- 0393-2990
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
The objective was to assess the occurrence of miscarriages, low birth weight, and karyotype abnormalities found with low and elevated maternal serum alpha-fetoprotein (MSAFP) among women who had genetic amniocentesis performed. A retrospective study of 2,159 women who had MSAFP analysis prior to amn
## BACKGROUND: Our objective was to determine the frequency of adverse outcomes after maternal exposure to simvastatin and/or lovastatin during pregnancy in postmarketing experience. METHODS: We reviewed the Merck & Co., Inc. (West Point, PA) pharmacovigilance database for reports of exposure to s
infants have increased from 54.3% in 1988 to 62.4% in 1997. Six-month breastfeeding rates have also increased for all infants from 19.5% to 26.0% during the same years. The rates for low birth weight infants have also increased (2). Although it is reassuring that breastfeeding is on the rise, it is